Published in Vaccine Weekly, October 5th, 1998
Previous studies have shown that zanamivir given by nasal spray is effective in preventing infection and in decreasing the severity and duration of illness in experimental influenza infections. Inhaled zanamivir is effective in treating acute influenza, however, this was the first study to show that the drug is also effective when administered by a systemic route in humans. That findings suggest that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly